Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.

Schwartz EJ, Bodine EN, Blower S.

Hum Vaccin. 2007 Nov-Dec;3(6):231-8.

PMID:
17881889
2.

Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.

Schwartz EJ, Blower S.

J Infect Dis. 2005 May 15;191(10):1734-46. Epub 2005 Apr 13.

PMID:
15838802
3.

Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.

Stanberry LR.

Herpes. 2004 Aug;11 Suppl 3:161A-169A. Review.

PMID:
15319086
4.

The potential epidemiological impact of a genital herpes vaccine for women.

Garnett GP, Dubin G, Slaoui M, Darcis T.

Sex Transm Infect. 2004 Feb;80(1):24-9.

5.

Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.

Blower S, Wald A, Gershengorn H, Wang F, Corey L.

J Infect Dis. 2004 Nov 1;190(9):1610-7. Epub 2004 Sep 30.

PMID:
15478066
6.

Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.

Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE.

J Virol. 2005 Jan;79(1):410-8. Erratum in: J Virol. 2005 Apr;79(7):4554.

7.

Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.

Alsallaq RA, Schiffer JT, Longini IM Jr, Wald A, Corey L, Abu-Raddad LJ.

Sex Transm Dis. 2010 May;37(5):290-7. doi: 10.1097/OLQ.0b013e3181d3d023.

8.

Modelling the genital herpes epidemic.

Blower S.

Herpes. 2004 Aug;11 Suppl 3:138A-146A. Review.

PMID:
15319083
9.

Vaccines for herpes simplex virus infections.

Koelle DM.

Curr Opin Investig Drugs. 2006 Feb;7(2):136-41. Review.

PMID:
16499283
10.

Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.

Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.

J Infect Dis. 2005 Dec 15;192(12):2117-23. Epub 2005 Nov 11.

PMID:
16288376
11.

An update on short-course episodic and prevention therapies for herpes genitalis.

Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L.

Herpes. 2007 Jun;14 Suppl 1:5A-11A. Review.

PMID:
17877886
12.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
13.

[An epidemiological model of genital herpes for assessment of potential impact of therapy and prophylaxis: application to France].

Boƫlle PY, Fagnani F, Valleron AJ, Detournay B, El Hasnaoui A, Halioua B, Nicolas JC.

Ann Dermatol Venereol. 2004 Jan;131(1 Pt 1):17-26. French.

PMID:
15041839
15.

Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.

Jones CA, Cunningham AL.

Herpes. 2004 Apr;11(1):12-7. Review.

PMID:
15115632
16.

Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.

Jazayeri M, Soleimanjahi H, Fotouhi F, Pakravan N.

Comp Immunol Microbiol Infect Dis. 2009 Sep;32(5):453-61. doi: 10.1016/j.cimid.2008.05.002. Epub 2008 Jun 20.

PMID:
18571235
17.

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.

Antiviral Res. 2004 Aug;63 Suppl 1:S3-9. Review.

PMID:
15450380
18.

Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.

Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F.

FEMS Immunol Med Microbiol. 2008 Oct;54(1):18-26. doi: 10.1111/j.1574-695X.2008.00438.x. Epub 2008 Jul 21.

19.

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.

Garnett GP.

J Infect Dis. 2005 Feb 1;191 Suppl 1:S97-106. Review.

PMID:
15627236
20.

Control of STDs--the role of prophylactic vaccines against herpes simplex virus.

Stanberry LR.

Sex Transm Infect. 1998 Dec;74(6):391-4. Review.

Supplemental Content

Support Center